|
Re: Looking for clues:
|
2
|
Resverlogix Corp.
|
Nov 30, 2019 01:55AM
|
|
Re: Sent this to IR
|
2
|
Resverlogix Corp.
|
Nov 17, 2023 12:36PM
|
|
Re: Looking for clues:
|
2
|
Resverlogix Corp.
|
Nov 30, 2019 07:20PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Dec 11, 2019 04:44PM
|
|
Re: Trial Status
|
2
|
Resverlogix Corp.
|
Jul 20, 2021 12:55PM
|
|
Re: Funny
|
2
|
Resverlogix Corp.
|
Mar 19, 2020 07:00PM
|
|
Re: Anybody ever post this link already?
|
3
|
Resverlogix Corp.
|
Apr 14, 2023 12:30PM
|
|
Barron's rating; albeit a single analyst:
|
3
|
Resverlogix Corp.
|
Dec 06, 2022 01:05PM
|
|
Re: Still not finding on ClinicalTrials gov
|
3
|
Resverlogix Corp.
|
Apr 23, 2021 01:28PM
|
|
Re: Looking for clues:
|
3
|
Resverlogix Corp.
|
Nov 30, 2019 07:41PM
|
|
Epigentic headline:
|
3
|
Resverlogix Corp.
|
May 01, 2024 01:14PM
|
|
A brief news piece dated yesterday...
|
3
|
Resverlogix Corp.
|
Feb 18, 2020 10:09PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jun 06, 2023 10:02PM
|
|
Re: Still not finding on ClinicalTrials gov
|
4
|
Resverlogix Corp.
|
Apr 21, 2021 10:29PM
|
|
Recent article; published in Clinical Epigenetics
|
4
|
Resverlogix Corp.
|
Jan 13, 2023 01:29PM
|
|
Re: balancing success and failure
|
4
|
Resverlogix Corp.
|
Nov 19, 2019 08:42PM
|
|
Re: Barron's rating; albeit a single analyst:
|
4
|
Resverlogix Corp.
|
Dec 07, 2022 03:59PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
5
|
Resverlogix Corp.
|
Feb 13, 2020 10:24PM
|
|
Re: eGFR and Cognition?
|
6
|
Resverlogix Corp.
|
Nov 22, 2019 10:48PM
|
|
Looking for clues:
|
6
|
Resverlogix Corp.
|
Nov 29, 2019 09:40PM
|
